Chargement en cours...
Pediatric Depression Treatment in the Aftermath of the Black Box Warning: Implications for Prescription Drug Policy
In 2004, the Food and Drug Administration (FDA) directed pharmaceutical manufacturers to add a black box warning to antidepressants describing an increased suicide risk in children. We describe the events and evidence that led the FDA to act, the specific actions taken by the agency, and the changes...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2768536/ https://ncbi.nlm.nih.gov/pubmed/19414881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1377/hlthaff.28.3.724 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|